Maung Tin, MD Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 99 Oak Ave Apt 217, South San Francisco, CA 94080 Phone: 646-920-7685 |
Dr. James Nicholas Peros, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Edmond L. Schmulbach, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Tom A. Vo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
William Chung, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Aruna K. Chinnakotla, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Anthony Tun Thu, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Timothy E. Liao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Dr. Elaine Rose Murray, MD Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Edward Fang, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Dr. Elwyn Loh, M.D. Internal Medicine - Medical Oncology Medicare: Not Enrolled in Medicare Practice Location: 1120 Veterans Blvd, South San Francisco, CA 94080 Phone: 650-244-2868 |
Dr. Michael David Genualdi, M.D. Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 395 Oyster Point Blvd Ste 512, South San Francisco, CA 94080 Phone: 657-237-2450 |
Lawrence B. Lusk, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Waichi Chan, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Bambi L. Menes, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
James J. Gibboney, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Alaap Mehta, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Najm U. Haq, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Sharon Inokuchi, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1200 El Camino Real, South San Francisco, CA 94080 Phone: 650-742-2000 |
Faith Wells, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 395 Oyster Point Blvd Ste 512, South San Francisco, CA 94080 Phone: 650-826-2945 |
News Archive
Nektar Therapeutics reported that partner Baxter International Inc. today announced that the company has submitted a biologics license application (BLA) to the United States Food and Drug Administration for the approval of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].
Walking or jogging helps patients with advanced gastrointestinal cancer to cope better with the side effects of chemotherapy.
By comparing 140 sequenced bacterial genomes, researchers have uncovered a system for regulating genes essential to bacterial replication - and they did it solely by computer keystrokes and mouse clicks.
Silence Therapeutics plc today announced that the United States Patent and Trademark Office (USPTO) has issued the company a notice of allowance on a patent application directed to methods of treatment using a high-value therapeutic target in the area of oncology. Known as PKN-3, the target is a protein kinase C-related molecule that is believed to play an important role in the growth of cancer cells, as well as metastasis formation.
A drug currently being used to treat ischemic strokes may prove to be a significant advance in the treatment of tuberculosis and ulcers. In a new research report appearing online in The FASEB Journal, a compound called ebselen effectively inhibits the thioredoxin reductase system in a wide variety of bacteria, including Helicobacter pylori which causes gastric ulcers and Mycobacterium tuberculosis which causes tuberculosis.
› Verified 9 days ago